Michael A, Syrigos K, Pandha H
Oncology Department, Postgraduate Medical School, University of Surrey, Surrey, UK.
Prostate Cancer Prostatic Dis. 2009;12(1):13-6. doi: 10.1038/pcan.2008.32. Epub 2008 Jun 3.
Prostate cancer is the most common cancer in men accounting for around 24% of all male cancers in United Kingdom. The role of chemotherapy in the neoadjuvant and adjuvant setting is still unclear despite considerable progress in this area. Chemotherapy for advanced prostate cancer has become the standard of care, however options of treatment following taxotere failure are still limited. This review summarizes recent advances in chemotherapy treatment options for early as well as advanced prostate cancer.
前列腺癌是男性中最常见的癌症，在英国约占所有男性癌症的24%。尽管该领域取得了显著进展，但化疗在新辅助和辅助治疗中的作用仍不明确。晚期前列腺癌的化疗已成为标准治疗方法，然而，多西他赛治疗失败后的治疗选择仍然有限。本综述总结了早期和晚期前列腺癌化疗治疗方案的最新进展。
